Novel perspectives on the pharmacological treatment of thyroid-associated ophthalmopathy
Thyroid-associated ophthalmopathy (TAO), an autoimmune disease closely related to thyroid dysfunction, remains a challenging ophthalmic condition among adults. Its clinical manifestations are complex and diverse, and disease progression can lead to exophthalmos, diplopia, exposure keratitis, corneal...
Saved in:
Main Author: | Zilin Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2024.1469268/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Exploring new horizons in CAR-based therapy for the treatment of thyroid-associated ophthalmopathy
by: Xin-Yu Zhu, et al.
Published: (2025-01-01) -
Histogram of Apparent Diffusion Coefficient to Evaluate the Activity of Thyroid‐Associated Ophthalmopathy
by: Defu Li, et al.
Published: (2025-01-01) -
Causal association between non-thyroidal autoimmune diseases and Graves' ophthalmopathy: A mendelian randomization study
by: Lan Ma, et al.
Published: (2025-02-01) -
The role of autophagy in Graves disease: knowns and unknowns
by: Hayder M. Al-kuraishy, et al.
Published: (2025-01-01) -
Validation of Indonesian Graves’ Ophthalmopathy Quality of Life Questionnaire and Its Association with Clinical Activity and Severity of Graves’ Ophthalmopathy
by: Cecilia Anggraini, et al.
Published: (2024-10-01)